DNTH
Price
$88.33
Change
+$0.01 (+0.01%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
4.91B
34 days until earnings call
Intraday BUY SELL Signals
ORKA
Price
$84.49
Change
+$1.07 (+1.28%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
5.57B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNTH vs ORKA

DNTH vs ORKA Comparison Chart in %
View a ticker or compare two or three
VS
DNTH vs. ORKA commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and ORKA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
DNTH vs ORKA: Fundamental Ratings
DNTH
ORKA
OUTLOOK RATING
1..100
5768
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
10100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
4335
P/E GROWTH RATING
1..100
52100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORKA's Valuation (39) in the null industry is somewhat better than the same rating for DNTH (80). This means that ORKA’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (10) in the null industry is significantly better than the same rating for ORKA (100). This means that DNTH’s stock grew significantly faster than ORKA’s over the last 12 months.

ORKA's SMR Rating (94) in the null industry is in the same range as DNTH (96). This means that ORKA’s stock grew similarly to DNTH’s over the last 12 months.

ORKA's Price Growth Rating (35) in the null industry is in the same range as DNTH (43). This means that ORKA’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for ORKA (100). This means that DNTH’s stock grew somewhat faster than ORKA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHORKA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (DNTH: $88.32 vs. ORKA: $83.42)
Brand notoriety: DNTH and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 109% vs. ORKA: 98%
Market capitalization -- DNTH: $4.91B vs. ORKA: $5.57B
DNTH [@Biotechnology] is valued at $4.91B. ORKA’s [@Biotechnology] market capitalization is $5.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 1 FA rating(s) are green while ORKA’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 1 green, 4 red.
  • ORKA’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than ORKA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while ORKA’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 5 bearish.
  • ORKA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than ORKA.

Price Growth

DNTH (@Biotechnology) experienced а -2.63% price change this week, while ORKA (@Biotechnology) price change was -2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 05, 2026.

ORKA is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNTH
Daily Signal:
Gain/Loss:
ORKA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
REK16.890.11
+0.66%
ProShares Short Real Estate (REK)
GF10.680.04
+0.38%
NEW Germany Fund
CDC71.680.13
+0.18%
VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC)
CPSM29.610.01
+0.03%
Calamos S&P 500 Structured Alt Protection ETF (CPSM)
FNDE41.66-0.21
-0.50%
Schwab Fundamental Emerging Markets Equity ETF (FNDE)

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with EDIT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.31%
EDIT - DNTH
46%
Loosely correlated
-1.95%
XENE - DNTH
44%
Loosely correlated
+4.68%
IMTX - DNTH
42%
Loosely correlated
-3.87%
ORKA - DNTH
42%
Loosely correlated
+0.16%
REPL - DNTH
41%
Loosely correlated
+1.59%
More

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with SYRE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
+0.16%
SYRE - ORKA
50%
Loosely correlated
+1.01%
CGON - ORKA
43%
Loosely correlated
-3.58%
DNTH - ORKA
41%
Loosely correlated
+0.31%
BCAX - ORKA
41%
Loosely correlated
-2.20%
ENTA - ORKA
41%
Loosely correlated
-2.58%
More